New radioactive tracer could sharpen cancer scans
NCT ID NCT05989997
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-phase trial tested a new radioactive imaging agent called 68Ga-NOTA-SNA002 in 17 adults with solid tumors. The agent was injected into a vein, and researchers checked its safety, how it spreads in the body, and how well it shows up on PET scans. The goal was to see if this tracer could help doctors better see and understand tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
68Ga-NOTA-SNA002 (a radioactive imaging agent injected into a vein for PET scans)
What this could lead to
If successful, this could lead to a new way to see tumors on PET scans, helping doctors diagnose and monitor cancer more accurately.
What could go wrong
This is a very early, small Phase 1 trial focused on safety and imaging, not treatment. It may not lead to a widely used diagnostic tool, and the agent could cause side effects or unclear images.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital Affiliated to Fudan University
Shanghai, China